Asbury Park, NJ, November 20, 2014 ― The Asbury Park Press has published an op-ed by HealthCare Institute of New Jersey (HINJ) President and Chief Executive Officer Dean Paranicas regarding New Jersey’s “2.0 business environment” and its impact on the state’s life sciences community.
* * *
There have been reports that claim that New Jersey is no longer the pharmaceutical powerhouse it used to be, including a recent Asbury Park Press story by Michael L. Diamond (“What NJ Needs to Learn from Other States,” October 18, 2014).
We disagree. To paraphrase Mark Twain, reports of New Jersey’s demise are greatly exaggerated.
For decades, New Jersey has rightly earned its reputation as the “Medicine Chest of the World” — and our state leaders are working with the life sciences industry to keep it that way. Read the rest of this entry »